Heppenheimer
Well-Known Member
The vote is in for the pediatric vaccination... 17 votes in favor of EAU and one abstention.
The FDA committee notes, however, that they expect that the proposed dosing schedule will likely change with more experience with the vaccine.
The committee also stated that although the overall benefit greatly outweighs the risk, we will need to monitor the incidence of myocarditis very closely, since the trial wasn't sufficiently powered to detect this possible complication.
The FDA committee notes, however, that they expect that the proposed dosing schedule will likely change with more experience with the vaccine.
The committee also stated that although the overall benefit greatly outweighs the risk, we will need to monitor the incidence of myocarditis very closely, since the trial wasn't sufficiently powered to detect this possible complication.